nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2019, 10, v.28 1207-1211
脱氢表雄酮应用在不同年龄阶段的卵巢储备功能下降患者的疗效观察
基金项目(Foundation): 肇庆市科技创新指导类项目(201804030906)
邮箱(Email):
DOI:
发布时间: 2019-10-12
出版时间: 2019-10-12
移动端阅读
摘要:

目的观察脱氢表雄酮(DHEA)应用在不同年龄阶段的卵巢储备功能下降(DOR)患者的疗效。方法回顾性分析在我院进行IVF助孕治疗前行DHEA预处理的220例DOR患者资料,按年龄分为3组:<35岁为A组(40例),35~40岁为B组(80例),>40岁为C组(100例)。比较不同年龄组患者助孕过程参数及临床结局。结果 DHEA预处理前,3组患者间基础性激素水平和窦卵泡计数(AFC)均无统计学差异(P>0.05)。DHEA预处理后,3组患者的基础FSH、E2水平均显著下降(P<0.05),而LH、AMH水平、AFC并无显著改善(P>0.05)。A组在获卵数、获卵率、受精率、优质胚胎率、FET胚胎种植率、FET临床妊娠率均显著优于B、C两组(P<0.05),3组患者间Gn总剂量及使用天数、HCG日E2水平、卵裂率均无统计学差异(P>0.05)。结论 DHEA辅助治疗可使DOR患者中的年轻人群反应性显著提升,进而使其卵巢储备功能得到改善,最终改善IVF治疗的结局;而>35岁的DOR患者使用DHEA后没有明显疗效。

Abstract:

Objective:To observe the efficacy of dehydroepiandrosterone(DHEA)in patients with decreased ovarian reserve(DOR)in different age.Methods:The data 220 patients with DOR undergone IVF in our hospital were retrospectively analyzed.The patients were divided into 3 groups according to age:<35 years old in group A(n=40),35-40 years old in group B(n=80),and>40 years old in group C(n=100).The parameters of the assisted pregnancy process and clinical outcomes were compared among different age groups.Results:There was no significant difference in basal sex hormone levels and antral follicle count(AFC)before DHEA treatment among the three groups(P>0.05).The basal FSH and E2 levels were decreased after DHEA treatment in the three groups(P<0.05),but there was no significant improvement in LH,AMH level and AFC(P>0.05).The number of oocytes retrieved,oocyte retrieval rate,fertilization rate,high quality embryo rate,FET embryo implantation rate and FET clinical pregnancy rate in group A were significantly better than those in group B and C(P<0.05).The doses of Gn used,days of Gn used,E2 level on HCG day and cleavage rate were not significantly different among the three groups(P>0.05).Conclusions:Administration of DHEA as adjuvant therapy can significantly improve younger DOR patients' ovarian response,and thus improve their ovarian reserve function,ultimately improve the outcome of IVF treatment.There was no significant effect of DHEA pre-treatment on those>35-year-old DOR patients.

参考文献

[1]滑玮,武雁,张翠翠,等.脱氢表雄酮对卵巢低反应患者体外受精-胚胎移植周期的影响[J].山西医科大学学报,2016,47:470-474.

[2]林碎玲,刘大艳,李雪梅,等.DHEA对卵巢储备功能下降患者IVF周期胚胎质量的影响[J].中国优生与遗传杂志,2017,25:126-128.

[3]许晓璐,刘芸,黄吴键,等.卵巢储备功能减退患者应用脱氢表雄酮预处理的有效性研究[J].生殖医学杂志,2017,26:1145-1148.

[4]龚瑜,周黎明,蔡婕,等.脱氢表雄酮对卵巢储备功能下降患者卵巢反应性和IVF-ET结局的影响[J].生殖医学杂志,2017,26:675-678.

[5] Gleicher N,Barad DH.Dehydroepiandrosterone(DHEA)supplementation in diminished ovarian reserve(DOR)[J].Reprod Biol Endocrinol,2011,9:67-79.

[6] Frattarelli JL,Hill MJ,McWilliams GD,et al.A luteal estradiol protocol for expected poor-responders improves embryo number and quality[J].Fertil Steril,2008,89:1118-1122.

[7]叶雅萍,欧奇志,覃爱平.育龄女性血清硫酸脱氢表雄酮(DHEA-S)检测分析及其临床意义[J].生殖与避孕,2013,33:755-759.

[8]董娟,徐望明,董兰,等.IVF-ET前使用脱氢表雄酮对卵巢储备功能低下患者妊娠结局影响的系统评估[J].生殖医学杂志,2015,24:436-443.

[9] Snmezer M,Ozmen B.Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders[J/OL].Reprod Biomed Online,2009,19:508-513.

[10] Zhang J,Qiu X,Gui Y,et al.Dehydroepiandrosterone improves the ovarian reserve of women with diminished ovarian reserve and is a potential regulator of the immune response in the ovaries[J].Biosci Trends,2016,9:350-359.

[11] Gleicher N,Kim A,Weghofer A,et al.Starting and resulting testosterone levels after androgensupplementation determine at all ages in vitro fertilization(IVF)pregnancy rates in women with diminished ovarian reserve(DOR)[J].J Assist Reprod Genet,2013,30:49-62.

[12]胡蓉.脱氢表雄酮在卵巢储备功能降低患者体外受精-胚胎移植中的应用[J].国际生殖健康/计划生育杂志,2013,32:832-835.

[13]买尔哈巴·阿巴拜克力.探讨DHEA对卵巢储备功能低下患者血清FSH值及IVF周期胚胎质量的影响[D].新疆医科大学,2012.

[14]许晓璐,刘芸.脱氢表雄酮在卵巢储备功能减退患者中的应用研究进展[J].生殖医学杂志,2017,26:382-386.

[15] Casson PR, Lindsay MS, Pisarska MD, et al.Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders:a case series[J].Hum Reprod,2000,15:2129-2132.

[16] Barad D,Gleicher N.Effect of dehydroepiandrosterone on oocyte and embryo yields,embryo grade and cell number in IVF[J].Hum Reprod,2006,21:2845-2849.

[17] Barad D,Brill H,Gleicher N.Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function[J].J Assist Reprod Genet,2007,24:629-634.

[18] Kara M,Aydin T,Aran T,et al.Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?[J].Eur J Obstet Gynecol Reprod Biol,2014,173:63-65.

[19] Vlahos N, Papalouka M, Triantafyllidou O,et al.Dehydroepiandrosterone administration before IVF in poor responders:a prospective cohort study[J/OL].Reprod Biomed Online,2015,30:191-196.

基本信息:

中图分类号:R714.8

引用信息:

[1]夏军燕,涂艳琴,左银花.脱氢表雄酮应用在不同年龄阶段的卵巢储备功能下降患者的疗效观察[J].生殖医学杂志,2019,28(10):1207-1211.

基金信息:

肇庆市科技创新指导类项目(201804030906)

发布时间:

2019-10-12

出版时间:

2019-10-12

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文